Zydus introduces cancer treatment IBYRA in India, making advanced therapy accessible

Pallavi Madhiraju- March 13, 2024

In a groundbreaking development for cancer treatment in India, Zydus Lifesciences has launched Olaparib under the brand name IBYRA, a pioneering PARP inhibitor designed to ... Read More